N-terminal modifications of the chemokine RANTES bind to C-C chemokine rece
ptor 5 (CCR5) and block human immunodeficiency virus type 1 (HIV-1) infecti
on with greater efficacy than native RANTES. Modified RANTES compounds indu
ce rapid CCR5 internalization and much slower receptor reexpression than na
tive RANTES, suggesting that receptor sequestration is one mode of anti-HIV
activity. The rates of CCR5 internalization and reexpression,were compared
using the potent n-nonanoyl. (NNY)-RANTES derivative and CD4(+) T cells de
rived from donors with different CCR5 gene polymorphisms. NNY-RANTES caused
even more rapid receptor internalization and slower reexpression than amin
ooxypentane (AOP)-RANTES. Polymorphisms in the promoter and coding regions
of CCR5 significantly affected the receptor reexpression rate after exposur
e of cells to NNY-RANTES. These observations may be relevant for understand
ing the protective effects of different CCR5 genotypes against HIV-1 diseas
e progression.